Eazysense Nanotechnologies Inc. presents to you "The Covid Brain". Welcome to the 23rd, that is the 46th Show of Easysense in its Second Season. We are on the air for Easysense on the Bold, Brave Media and Tune in Radio Talk Show! Easysense is helping all people and animals through the pandemic! Bold Brave Media is making significant investments for Easysense and we thank Eddie and Tom!!!! Perry is my great engineer.
......the data from the BRODERICK PROBE biosensor -I'm Professor at the City University of New York School of Medicine and to the University City College of New York and NYU Langone Medical Center.
· WASHINGTON — The Food and Drug Administration announced Sunday that it has authorized the use of blood plasma from patients who have recovered from Covid-19 as a treatment for the disease........ convalescent plasma is among a host of potential therapeutics that have been undergoing testing in clinical trials. The hope is that infusions of antibody-rich plasma from those who have recovered from Covid-19 can be injected into ill patients, kickstarting their immune system and allowing them to fight off the virus until they can generate their own antibodies.Alex Azar, secretary of Health and Human Services.. "We dream in drug development of something like a 35% mortality reduction," he said. "This is a major advance in the treatment of patients." There's more-back and forth and so on...CDC- 6 percent of covid cases were truly covid and the rest-co-morbid and complications. .......
· News-corporate lawyer! We have it for Eazysense
· Book signing-Top Innovator-will let you know.
Teaching 200 students Med 10000
· Canada-Bill Tong's Advisory Board
· (1) Patricia A. Broderick (Distinguished Scientific Advisor)
· (2) Richi Gill (Scientific Advisor)
· (3) Jui-Yang (Gilbert) Hong, PhD (Scientific Advisor)
· (4) Sam Neymotin (Scientific Advisor)
· (5) Brandon Apparcel (Business Advisor)
· Discussing ----
The New Yorker Annals of Technology August 29, 2020. Gideon Lewis-Krause
Detect! Rothberg told his core staff not to worry about competitors—he expected that most of them would be focused on antibody tests, which can only diagnose in retrospect and have often proved untrustworthy, or antigen tests, which register the presence of viral proteins. These can be quick and inexpensive but aren't generally as accurate as molecular tests, which indicate not the presence of a viral proxy, like a protein, but of the virus itself. Rothberg's predictions were almost immediately confirmed: a small Massachusetts startup, E25Bio, soon announced that they had raised millions of dollars of venture capital, and anticipated approval for their fifteen-minute at-home antigen test within two months.
........however, as a pioneer of "next-generation sequencing," a major advance in the speed with which a genome could be read. The consequences of this breakthrough for personalized health, forensic investigation, and the study of human prehistory, to take only a few examples, have been breathtaking; in 2016, President Barack Obama bestowed upon him the National Medal of Technology and Innovation for his achievement
Guests.....
Viren Seghal-undergrad-MED 10000 CCNY
Jim Hordof-MS-CUNY-biology -neuroscience-CUNY Grad Ctr
significant investments are here........
Significant contributions 501(c)3 to PO Box 596 and the address is 3630 E. Tremont Ave. Bx, NY 10465.
Manufacturer for customized photodiodes needed.
Quick five dollars to brainwork@eazysense.com through zelle quick pay.
Websites-
www.eazysense.com
www.eazysensenanotechnologies.com
www.eazysensationalbrainimaging
